China Jo-Jo Drugstores (CJJD) Reports Q2 EPS of $0.04

China Jo-Jo Drugstores (NASDAQ: CJJD) reported Q2 EPS of $0.04, versus $0.00 reported last year. Revenue for the quarter came in at $20.2 million, versus $22.6 million reported last year.

Mr. Lei Liu, China Jo-Jo's Chairman and CEO, commented, "Our gross margin continued to expand, benefiting from more vendor rebates attributable to our focused marketing efforts in promoting brand-name pharmaceutical products, as we believe selling these products enhances our store popularity and customer loyalty. During the quarter, we achieved sales volume with certain brand pharmaceutical suppliers and received substantial rebates. In addition, now that the G20 summit is behind us, we have normalized our marketing activities and expect a rebound in retail sales in the third quarter."

For earnings history and earnings-related data on China Jo-Jo Drugstores (CJJD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Optimum Communications gets NYSE non-compliance notice over stock price